[1] 石玉玲,廖扬,曾珠,等.血清降钙素原在下呼吸道感染疾病中的诊断与应用[J].中华医院感染学杂志,2010,20(1):44-46.
[2] 张立,林勇.降钙素原在呼吸系统感染性疾病诊断及治疗中的应用[J].东南大学学报(医学版),2011,30(4):643-648.
[3] 陈国强,曹华英,姚正国,等.血清降钙素原水平区分重症监护病房患者革兰阳性菌与革兰阴性菌感染的研究[J].中华医院感染学杂志,2009,19(15):1944-1946.
[4] Charles PE,Ladoire S,Aho S,et al.Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria[J].BMC Infect Dis,2008,8(1):38.
[5] 盘毅辉,邓孙林,蒋亚斌.重症急性胰腺炎患者检测降钙素原和C反应蛋白的临床意义[J].中国实用医药,2013,8(2):26-27.
[6] Ammori BJ,Becker KL,Kite P,et al.Calcitonin precursors:early markers of gut barrier dysfunction in patients with acute pancreatitis[J].Pancreas,2003,27(3):239-243.
[7] Luzzani A,Polati E,Dorizzi R,et al.Comparison of procalcitonin andC-reactive protein as markers of sepsis[J].Crit Care Med,2003,31(6):1737-1741.
[8] Maruna P,Nedelniková K, Gürlich R.Physiology and genetics of procalcitonin[J].Physiol Res, 2000,49(Suppl 1):S57-61.
[9] Christ-Crain M,Jaccard-Stolz D,Bingisser R,et al.Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections:cluster-randomised, single-blinded intervention trial[J].Lancet,2004,363(9409):600-607.
[10] Bezmarević M,Kostić Z,Jovanović M,et al.Procalcitonin and BISAP score versus C-reactive protein and APACHE Ⅱ score in early assessment of severity and outcome of acute pancreatitis[J].Vojnosanit Pregl,2012,69(5):425-431.
[11] Mofidi R,Suttie SA,Patil PV,et al.The value of procalcitonin at predicting the severity of acute pancreatitis and development of infected pancreatic necrosis:systematic review[J]. Surgery,2009,146(1):72-81.
[12] Muller CA,Uhl W,Printzen G,et al.Role of procalcitonin and granulocyte colony stimulating factor in the early prediction of infected necrosis in severe acute pancreatitis[J].Gut, 2000,46(2):233-238.
[13] Swardfager W,Herrmann N,Cornish S,et al.Exercise intervention and inflammatory markers in coronary artery disease:a meta-analysis[J].Am Heart J,2012,163(4):666-676.
[14] Bayes-Genis A,Conover CA,Overgaard MT,et al.Pregnancy-associated plasma protein A as a marker of acute coronary syndromes[J].N Engl J Med,2001,345(14):1022-1029.
[15] López-Andrés N,Rousseau A,Akhtar R,et al.Cardiotrophin 1 is involved in cardiac,vascular, and renal fibrosis and dysfunction[J].Hypertension,2012,60(2):563-573.
[16] Thygesen K,Alpert JS,White HD,et al.Universal definition of myocardial infarction[J].Eur Heart J,2007,28(20):2525-2538.
[17] Kojima M,Ohashi M,Dohi Y,et al.Titration of telmisartan,but not addition of amlodipine, reduces urine albumin in diabetic patients treated with telmisartan-diuretic[J].J Hypertens, 2013,31(1):186-191.
[18] Karaye KM.Relationship between Tei index and left ventricular geometric patterns in a hypertensive population:a cross-sectional study[J].Cardiovasc Uhrasound,2011,9(1):21.
[19] Vesely DL.Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure,renal failure and cancer?[J].Clin Exp Pharmacol Physiol,2006,33(3): 169-171.
[20] Shimizu Y,Yamasaki F,Furuno T,et al.Metabolic effect of combined telmisartan and nifedipine CR therapy in patients with essential hypertension[J].Int J Gen Med,2012,5(2):753-758.
[21] Krzesinski JM,Saint-Remy A.Essential hypertension,a complex trait[J].Rev Med Liege,2012,67(5-6):279-285.
[22] Padma G,Bhupatiraju C,Srinivas B,et al.High risk for essential hypertension in males conferred by g.15241A>G polymorphism in intron 3 of AGT gene[J].Clin Exp Hypertens,2013,35(2):108-111.
[23] Fang J,Ma L,Zhang S,et al.Association of myeloperoxidase gene variation with carotid atherosclerosis in patients with essential hypertension[J].Mol Med Rep,2013,7(1):313-317.
[24] Maruna P,Frasko R,Gürlich R.Plasma procalcitonin in patients with ileus. Relations to other inflammatory parameters[J].Physiol Res,2008,57(3):481-486. |
